Clinical trial · no report yet · Phase 1/Phase 2
ARTACUS
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
- NCT04349436 ↗
- Active not recruiting
- Replimune, Inc.
- 6 commentary sources found
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built. Commentary is thin so far, so the report would be short.
| Channel | Found | |
|---|---|---|
| YouTube | 5 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)
- Phase
- Phase 1/Phase 2
- Status
- Active not recruiting
- Conditions
- Merkel Cell Carcinoma; Basal Cell Carcinoma; Locally Advanced Cutaneous Squamous Cell Carcinoma; Cancer
- Interventions
- RP1, intra-tumoral injection, oncolytic virus
- Arms
- RP1, intra-tumoral injection, oncolytic virus · Experimental
- Enrollment
- 69
- Primary outcomes
- Primary Objective for Patients with Locally Advances CSCC (laCSCC)
- Primary Efficacy Objective for Patients with Other Skin Cancers
- Primary Safety Objective for Patients with Other Skin Cancers
- Sponsor
- Replimune, Inc.
- Start
- May 15, 2020
- Primary completion
- Jul 2029 (estimated)
- Results posted
- No
- Registry record
- NCT04349436 · updated Apr 22, 2026